CARSON CITY, Nev., Aug. 3, 2006 (PRIMEZONE) -- Avitech Lifesciences Inc. (Other OTC:AVLF) announced today that it is introducing an extended line of homeopathic products that it will market under the trade name Avi-Essence.
While continued focus and commitment remains on the Avian Flu, the Company has decided to expand their market by introducing a wide range of natural health products. In keeping with the corporate vision of directing our attention to the health and life sciences industry, Avitech has carefully selected these products to aid in the well-being of our new and existing customers.
The decision was encouraged by the growing public awareness and acceptance of natural health remedies throughout the world.
The Company is pleased to introduce Avi-Essence -- multi-vitamin (advanced pro-formula), weight reduction (extreme slim formula), antioxidant complex, digestive enzymes, joint relief (arthritis effect), hair growth formula, anti-aging complex, psoriasis cream, and human growth hormone.
The Avi-Essence brand of products have been produced by CMI Manufacturers Inc. CMI Manufacturers Inc. are well known for successfully producing some of the most innovative nutraceutical, pharmaceutical and cosmetic formulations that are available on the world-wide market today.
Avitech Lifesciences Inc. is currently updating its website to include detailed information regarding these products and their availability.
Please visit our website at www.avitechls.com for further information and developments.
About Avitech Lifesciences Inc.
Avitech Lifesciences Inc. is a firm focused on the health and life sciences industry. Avitech helps entrepreneurs accelerate their business development by investing early in the company's development and taking an active role in its day-to-day operations by acting as collaborative partners with the companies we bring on board. Although Avitech Lifesciences Inc.'s primary mandate is the health and life sciences sector, the company's mandate will allow it to look at all investments to increase shareholder value.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.